Shanghai Yizhong Pharmaceutical Co Ltd Class A 688091
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 65.62
- Price/Sales
- 24.40
- Dividend Yield (Trailing)
- 1.03%
- Dividend Yield (Forward)
- 1.03%
- Total Yield
- 1.03%
Company Profile
Shanghai Yizhong Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating research and development, production and sales. It is committed towards the development of new dosage forms of anti-tumor drugs and related products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 304
- Website
- http://www.yizhongpharma.com
Comparables
Valuation
|
Metric
|
688091
|
688553
|
000739
|
|---|---|---|---|
Price/Earnings (Normalized) | 65.62 | 53.62 | 18.32 |
Price/Book Value | 4.24 | 1.31 | 2.91 |
Price/Sales | 24.40 | 4.86 | 1.54 |
Price/Cash Flow | 95.58 | 27.30 | 9.69 |
Price/Earnings
688091
688553
000739
Financial Strength
|
Metric
|
688091
|
688553
|
000739
|
|---|---|---|---|
Quick Ratio | 12.24 | 2.65 | 0.97 |
Current Ratio | 12.80 | 2.93 | 1.30 |
Interest Coverage | 108.94 | 12.08 | 35.39 |
Quick Ratio
688091
688553
000739
Profitability
|
Metric
|
688091
|
688553
|
000739
|
|---|---|---|---|
Return on Assets (Normalized) | 6.90% | 1.73% | 7.96% |
Return on Equity (Normalized) | 7.29% | 2.13% | 16.93% |
Return on Invested Capital (Normalized) | 5.74% | 1.32% | 13.55% |
Return on Assets
688091
688553
000739
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Tjbtvjtxqj | Dhhy | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Bjrjxftqc | Zffmsnp | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Myjcljtt | Hzdl | $48.4 Bil | |||
| Viatris Inc
VTRS
| Yctsssqb | Chtvh | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Cnwwbsz | Svfp | $13.5 Bil | |||
| Catalent Inc
CTLT
| Xyyszgbhk | Hfhdfwc | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Mbwrdfs | Kfmvrp | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Ngbpqnfl | Lhq | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Rsyjjxcqc | Cpgd | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Chgvspht | Mgpy | $2.3 Bil |
United States